SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-060882
Filing Date
2024-05-14
Accepted
2024-05-14 07:30:53
Documents
15
Period of Report
2024-05-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414353d1_8k.htm   iXBRL 8-K 60584
2 EXHIBIT 3.1 tm2414353d1_ex3-1.htm EX-3.1 5746
3 EXHIBIT 10.1 tm2414353d1_ex10-1.htm EX-10.1 153602
  Complete submission text file 0001104659-24-060882.txt   439566

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20240513.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20240513_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20240513_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2414353d1_8k_htm.xml XML 3802
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 24941456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)